RxDoctor Payments Data

Christian Atkins, PA

Physician Assistant · Miami, FLNPI 1033542444

Payments from drug & device makers

$1,185in general payments, 2019–2025

Across 70 payments — averaging $16.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$419
  • Abbott$134
  • Lilly USA, LLC$117
  • Medtronic$71
  • Novo Nordisk$54
  • Amgen$51
  • plus $338 from 12 others

What the payments were for

  • Food & beverage$1,185100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,185 in reported general payments places this provider in the 65th percentile of 8,062 physician assistant providers in Florida.

See all physician assistant providers in Florida

Medicare billing

Part B allowed, 2024
$83,911
Medicare patients
297
Services billed
1,450

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide89$106,703
MounjaroTirzepatide44$52,515
EliquisApixaban50$50,537
JardianceEmpagliflozin22$36,887
XareltoRivaroxaban23$33,615
Budesonide ErBudesonide11$25,012
Trelegy ElliptaFluticasone/Umeclidin/Vilanter29$20,957
ProliaDenosumab12$20,634
FarxigaDapagliflozin Propanediol12$16,259
Soliqua 100-33Insulin Glargine/Lixisenatide11$8,494
LinzessLinaclotide11$7,646
Humalog Kwikpen U-100Insulin Lispro19$3,516
Atorvastatin Calcium388$3,232
Albuterol Sulfate HfaAlbuterol Sulfate96$3,019
Levothyroxine Sodium216$2,218

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$54$106,70389 claims
Lilly USA, LLCMounjaro$117$52,51544 claims
PfizerEliquis$33$50,53750 claims
Boehringer IngelheimJardiance$13$36,88722 claims
AmgenProlia$51$20,63412 claims
AstraZenecaFarxiga$27$16,25912 claims
AbbVieLinzess, Synthroid$419$9,68843 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 8,062 physician assistant providers in Florida.

Other physician assistant in Miami

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →